Recursion Pharmaceuticals (RXRX) Gross Profit Growth (1y) (2022 - 2026)
Recursion Pharmaceuticals (RXRX) Gross Profit Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 41.37% |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 7.76% |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | 16.94% |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | 68.41% |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | - |
| 10 | Recursion Pharmaceuticals | 1.61 Bn | 951.75 Mn | -6.02 Mn | 15.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.05% |
| Dec 31, 2025 | 357.80% |
| Sep 30, 2025 | -167.93% |
| Jun 30, 2025 | -117.98% |
| Mar 31, 2025 | -369.56% |
| Dec 31, 2024 | -916.63% |
| Sep 30, 2024 | 4,170.64% |
| Jun 30, 2024 | 219.14% |
| Mar 31, 2024 | 936.94% |
| Dec 31, 2023 | -64.39% |
| Sep 30, 2023 | 84.70% |
| Jun 30, 2023 | 124.95% |
| Mar 31, 2023 | 87.27% |
| Dec 31, 2022 | 11.96% |
| Sep 30, 2022 | -188.75% |
| Jun 30, 2022 | -357.08% |
| Mar 31, 2022 | -196.25% |